Press Releases
Washington, D.C. – Congressman Gus Bilirakis (R-FL), member of the Energy and Commerce Subcommittee on Health, tomorrow will be delivering a keynote speech for The Hill's A Discussion on Biosimilars, Patient Access & Affordability.
Washington, D.C. – Representative Gus Bilirakis (R-FL), member of the Energy and Commerce Health Committee, was named to serve on the Subcommittee on Health, the Subcommittee on Communications & Technology, and the Subcommittee on Commerce, Manufacturing, & Trade.
Washington, D.C. – Representative Gus Bilirakis (R-FL) is honored to join State Senator Simpson, State Representative Corcoran, State Representative Burgess and the Kiwanis Foundation to host a Holiday Farm Share Food Giveaway for those in need on December 6, 2014.
Washington, D.C.
U.S. Rep. Gus Bilirakis has introduced H.R. 5750 to Congress, known as the Orphan Product Extensions Now Accelerating Cures & Treatment — or the OPEN ACT.
Washington, D.C. – Representative Gus Bilirakis, member of the House Energy and Commerce Subcommittee on Health, today introduced H.R. 5750, the Orphan Product Extensions Now Accelerating Cures & Treatments (OPEN ACT).
U.S. Rep. Gus Bilirakis, R-Fla., the vice chairman of the House Committee on Veterans Affairs, testified in front of the House Veterans Affairs Subcommittee on Health on Wednesday about giving veterans more medical choices. Bilirakis showcased his "Creating Options for Veterans' Expedited Recovery (COVER) Act" in his testimony which includes alternative therapies in VA care.
Washington, D.C. – Representative Gus Bilirakis, Vice-Chairman of the House Committee on Veterans Affairs, today testified before the House Veterans Affairs Subcommittee on Health about his bill, the Creating Options for Veterans' Expedited Recovery (COVER) Act.
Washington, D.C. – Representative Gus Bilirakis issued the following statement on the Obama Administration's decision to move forward with Executive Action on immigration:
Washington, D.C. – Representative Gus Bilirakis, member of the House Energy and Commerce Subcommittee on Health, today continued his oversight of the Ebola crisis, questioning officials from the National Institute of Health (NIH), Centers for Disease Control (CDC), and Food and Drug Administration (FDA) about the development of medical products to treat Ebola.